Chewy (CHWY) Q2 2026: 7.3% Sales Growth and 6.8% Adjusted EBITDA Margin Signal Durable Market Share Gains Amid Consumer Pressure
Chewy demonstrated resilient growth and margin expansion in a stabilized but pressured pet market, driven by recurring revenue and strategic health initiatives. The company’s AI deployments and acquisitions are beginning to yield operational efficiencies and deepen customer engagement. Management’s raised guidance reflects confidence in sustaining profitable growth without reliance on broader market recovery.
Summary
- Recurring Revenue Strength: Autoship sales growth outpaced total net sales, underpinning revenue durability.
- Health Ecosystem Expansion: Chewy Vet Care and Modern Animal acquisitions contribute to differentiated growth platforms.
- AI-Enabled Efficiency: Early AI deployments already generating cost savings and productivity gains.
Business Overview
Chewy operates as a leading e-commerce platform specializing in pet products, supplies, and prescriptions. The company generates revenue primarily through online sales across consumables, hard goods, and health-related categories, supported by Autoship, a recurring subscription service. Major segments include core pet consumables, pet health services (Chewy Vet Care), and recently acquired businesses such as SmartPak and Modern Animal, which expand Chewy’s ecosystem and market reach.
Performance Analysis
In Q2 2026, Chewy reported net sales of $3.33 billion, a 7.3% year-over-year increase, with organic growth excluding SmartPak and Modern Animal at 5.7%. This growth was fueled by a 3.8% rise in active customers to 21.7 million and a 9.3% increase in Autoship customer sales, which represented 84.6% of total net sales. Net sales per active customer rose modestly to $602, supported by customer cohort maturation and cross-category adoption, despite ongoing discretionary spending pressures.
Adjusted EBITDA reached $226.7 million, with a margin of 6.8%, exceeding expectations largely due to timing-related benefits such as early tariff refunds and vendor rebates. Even after normalizing for these discrete items, the underlying business delivered solid year-over-year margin expansion, driven by sponsored ads growth, a favorable product mix shift towards health, and cost efficiencies from automation and AI. Gross margin remained stable year-over-year at 30.4%, with management anticipating modest sequential declines in Q3 consistent with seasonality and external cost pressures such as fuel.
- Customer Engagement: Active customer growth and Autoship penetration reinforce recurring revenue stability.
- Margin Expansion Drivers: Sponsored advertising, health category premiumization, and AI-enabled productivity improvements.
- Acquisition Integration: Modern Animal and SmartPak performed ahead of expectations, contributing incremental growth and margin impact.
Free cash flow was $90 million, down year-over-year due to timing but consistent with full-year expectations. The company’s capital allocation included $200 million in share repurchases and $400 million invested in the Modern Animal acquisition, supported by a new $600 million term loan.
Executive Commentary
"Chewy delivered strong results in the second quarter, continuing to gain share and expand profitability. Our recurring revenue base supports durable sales, while our expanding ecosystem and the growing contribution from Chewy Health drives structural wallet share gains."
Sumit Singh, CEO
"Adjusted EBITDA margin exceeded our expectations, supported by gross margin benefits and SG&A leverage from automation and AI. We continue to see attractive opportunities to invest in growth while maintaining disciplined returns."
Chris Deppe, CFO
Strategic Positioning
1. Strengthening Recurring Revenue Through Autoship
Autoship sales grew 9.3% year-over-year, outpacing overall sales growth and representing over 84% of net sales. This subscription service underpins Chewy’s predictable revenue model and customer loyalty, enabling efficient marketing spend and stable cash flow generation.
2. Expanding Health Ecosystem for Differentiated Growth
Chewy Vet Care achieved triple-digit revenue growth, and the Modern Animal acquisition performed ahead of expectations, reinforcing Chewy’s strategic pivot towards health services. These platforms deepen customer engagement and increase wallet share beyond traditional product sales.
3. AI Deployment Driving Structural Cost Reductions
AI initiatives, including the customer-facing assistant Kai and voice agent Cali, are beginning to yield tangible financial benefits. Management expects low tens of millions in cost savings for 2026, scaling to approximately $50 million annually by 2027, enhancing productivity and lowering variable costs.
4. Disciplined Capital Allocation Balancing Growth and Shareholder Returns
Chewy maintained a conservative balance sheet, raising $600 million in debt to fund acquisitions and repurchasing $200 million in shares. The company emphasizes investments with attractive returns while returning excess capital to shareholders opportunistically.
5. Navigating Consumer Pressure with Stable Market Share Gains
Despite a pressured pet market environment, Chewy outperformed the broader category by two to three times, supported by ongoing active customer growth, retention, and cross-category adoption. Management does not rely on a market rebound to drive results but focuses on controllable operational levers.
Key Considerations
Chewy’s Q2 results highlight a business balancing growth and profitability amid macroeconomic headwinds and evolving consumer behavior. Key considerations include:
- Discretionary Spending Pressure: Treats and discretionary consumables showed more pronounced moderation than core food and health products.
- Integration Momentum: Modern Animal and SmartPak acquisitions are ahead of plan, suggesting effective integration and cross-selling potential.
- AI as a Productivity Lever: Early-stage AI deployments provide a durable margin expansion lever but will also be partially reinvested to support growth.
- Customer Funnel Health: Continued active customer additions and retention underpin organic growth despite broader category softness.
- Capital Allocation Discipline: Share repurchases reflect management’s view of undervaluation, balanced against strategic investments.
Risks
Risks include continued consumer pressure in discretionary categories, potential integration challenges with acquisitions, and execution risk around scaling AI initiatives. Macroeconomic volatility and input cost inflation, notably fuel, could also pressure margins despite offsetting productivity gains. The company’s guidance assumes a stable consumer environment without a significant market rebound, which remains uncertain.
Forward Outlook
For Q3 2026, Chewy guided to net sales between $3.323 billion and $3.358 billion, reflecting 6.6% to 7.7% year-over-year growth, with organic growth of 5.3% to 6.2%. Adjusted EBITDA margins are expected to range from 6.6% to 6.7%, implying approximately 85 basis points of year-over-year expansion at the midpoint. Adjusted diluted earnings per share are projected around $0.39.
For full-year 2026, management narrowed net sales guidance to $13.46 billion to $13.57 billion, a 6.8% to 7.7% increase, including organic growth of 5.5% to 6.3%. Adjusted EBITDA margin guidance was raised slightly, now expected between 6.7% and 6.8%. Capital expenditures are forecasted at 1.5% to 2% of net sales, with share-based compensation flat year-over-year and an effective tax rate of 24% to 26%.
Takeaways
Chewy’s Q2 results affirm its position as a resilient leader in pet e-commerce, leveraging a strong recurring revenue model and diversified growth platforms. The company’s strategic investments in health services and AI-enabled productivity are beginning to translate into tangible financial benefits, supporting margin expansion amid a challenging consumer backdrop.
- Durable Growth Engine: Autoship’s growing penetration and active customer base expansion provide a stable foundation for sustained growth.
- Health Ecosystem as Differentiator: Scaling of Chewy Vet Care and Modern Animal positions the company to capture increasing wallet share in pet health.
- AI Integration Progress: Early AI deployments validate cost-saving potential and set the stage for continued margin improvement and reinvestment capacity.
Conclusion
Chewy’s disciplined execution and strategic investments enabled solid growth and profitability in Q2 2026 despite a pressured pet market. The company’s expanding health ecosystem and AI-driven efficiencies underpin confidence in its ability to compound earnings and free cash flow over time, independent of broader market recovery.
Industry Read-Through
Chewy’s performance illustrates the resilience of pet e-commerce amid macroeconomic headwinds, highlighting the importance of recurring revenue models and health-related service expansion. The integration of AI to improve customer experience and operational efficiency sets a benchmark for peers navigating cost pressures. Other industry participants should monitor Chewy’s health ecosystem progress and AI deployment as indicators of evolving competitive dynamics in pet retail.